ArticleAnalytical chemistry2025
Supervised Contrastive Learning Leads to More Reasonable Spectral Embeddings.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Benchmarking MS/MS Featurization Strategies for Machine Learning-Driven Metabolite Structure Annotation.Journal of the American Society for Mass Spectrometry · 2026Article
- Generalist biological artificial intelligence in modeling the language of life.Nature biotechnology · 2026Review
- A Framework for Database Search with AI Models in Mass Spectrometry-Based Proteomics.Journal of proteome research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past decades, mass spectrometry has served as a fundamental technique for molecular identification in the field of metabolomics, widely applied to the analysis and characterization of biomolecules. However, the complexity of experimental conditions and the structural similarities among compounds pose significant challenges for accurate identification. Recent advancements in deep learning have offered new solutions to address these challenges, particularly demonstrating great potential in generating high-quality spectral embeddings. In this study, we propose a novel method, SpecEmbedding, which leverages a transformer encoder architecture and employs replicated spectra of compounds as positive samples, trained under a supervised contrastive learning framework. By mapping complex mass spectra into low-dimensional vector representations, SpecEmbedding significantly enhances the comparability between spectra, thereby improving identification accuracy. We trained SpecEmbedding on the GNPS training subset and evaluated its performance on the GNPS test subset, the MoNA data set, and the MTBLS1572 data set. Experimental results show that SpecEmbedding achieves a Top-1 hit ratio of 81.73% on the GNPS test subset, substantially outperforming MSBERT (77.81%) and DreaMS (71.90%). The source code for this study is publicly available at https://github.com/sword-nan/SpecEmbedding. A web service is provided at https://huggingface.co/spaces/xp113280/SpecEmbedding.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.